Aphasia, Broca: Clinical Trials

3 trials for Aphasia, Broca, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 22Completed 1, Recruiting 1

Follow Aphasia, Broca: new trials by email Literature Review of Aphasia, Broca trials Research Report on Aphasia, Broca

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Superiority Trial of Aphasia-focused Rehabilitation With tDCS Stimulation
tDCS - Aphasia, Broca's Aphasia
Phase 2 / Phase 3RecruitingUniversity of South Carolina1302026-07-142026-07-21
Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients
Transcranial Magnetic Stimulation (TMS-r), Placebo Transcranial Magnetic Stimulation - Aphasia, Broca
Phase 3UnknownFundación Cardiovascular de Colombia1002014-08-012014-09-16
Augmenting Language Therapy for Aphasia: Levodopa
levodopa/carbidopa, Placebo comparator - Nonfluent Aphasia, Stroke
Phase 2 / Phase 3CompletedShirley Ryan AbilityLab362007-10-012013-12-25

Narrower conditions

Aphasia (3)  ·  Stroke (3)  ·  Ischemic Stroke (1)

Broader conditions

Brain Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Communication Disorders (3)  ·  Language Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Speech Disorders (3)  ·  Vascular Diseases (3)

Interventions

Transcranial Direct Current Stimulation (1)  ·  Transcranial Magnetic Stimulation (1)  ·  carbidopa, levodopa drug combination (1)

Sponsors

Fundación Cardiovascular de Colombia (1)  ·  Shirley Ryan AbilityLab (1)  ·  University of South Carolina (1)

Countries

United States (2)  ·  Colombia (1)

Top investigators

Federico A Silva, MD,MSc (1)

NIH funding

U01DC022447 (1)